BNP/CALL/STRYKER CORP./380/0.1/20.09.24 Stock

Warrant

DE000PC5FYD0

Market Closed - Börse Stuttgart 02:36:56 2024-06-19 am EDT
0.47 EUR +20.51% Intraday chart for BNP/CALL/STRYKER CORP./380/0.1/20.09.24
Current month-7.14%
1 month+25.81%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-19 0.47 +20.51%
24-06-18 0.39 -4.88%
24-06-17 0.41 +17.14%
24-06-14 0.35 -14.63%
24-06-13 0.41 -10.87%

Delayed Quote Börse Stuttgart

Last update June 19, 2024 at 02:36 am EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC5FYD
ISINDE000PC5FYD0
Date issued 2024-02-21
Strike 380 $
Maturity 2024-09-20 (93 Days)
Parity 10 : 1
Emission price 1.35
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 1.75
Lowest since issue 0.19
Spread 0.11
Spread %16.92%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
348.7 USD
Average target price
372.9 USD
Spread / Average Target
+6.96%
Consensus